Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse

References

• Russell DS, Rubinstein LJ. Medulloblastomas. In: Russell DS, Rubinstein LJ, editors. Pathology of tumours of the nervous system. 5th ed. Baltimore: Williams & Wilkins; 1989. p. 251–254.
   Google Scholar
• Spreafico F, Massimino M, Gandola L, et al Survival of adults treated for medulloblastoma using paediatric protocols. Eur J Cancer 2005;41:1304–1310.
   PubMed Web of Science ®Google Scholar
• Frost PJ, Laperpierre NJ, Wong CS, et al Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:951–957.
   PubMed Web of Science ®Google Scholar
• Carrie C, Lasset C, Alapetite C, et al Multivariate analysis of prognostic factors in adult patients with medulloblastoma. Cancer 1994;74:2352–2360.
   PubMed Web of Science ®Google Scholar
• Haie C, Schlienger M, Constans JP, et al Results of radiation treatment of medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1985;11:2051–2056.
   PubMed Web of Science ®Google Scholar
• Bloom HJG, Bessel EM. Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981. Int J Radiat Oncol Biol Phys 1990;18:763–772.
   PubMed Web of Science ®Google Scholar
• Carrie C, Lasset C, Blay JY, et al Medulloblastoma in adults: survival and prognostic factors. Radiother Oncol 1993;29:301–307.
   PubMed Web of Science ®Google Scholar
• Chan AW, Tarbell NJ, Black P, et al Adult medulloblastoma: prognostic factors and pattern of relapse. Neurosurgery 2000;47:623–632.
   PubMed Web of Science ®Google Scholar
• Chang CH, Housepian EM, Herbert C Jr. An operative staging system and a megavoltage radiotherapeutic technique for cerebellar medulloblastoma. Radiology 1969;93:1351–1359.
   PubMed Web of Science ®Google Scholar
• Evans AE, Jenkin RDT, Sposto R, et al The treatment of medulloblastoma: Results of a prospective randomized trial of radiation therapy with and without CCNLJ, vincristine and prednisone. J Neurosurg 1990;7:2572–2582.
   Google Scholar
• Tait DM, Thornton-Jones H, Bloom HJG, et al Adjuvant chemotherapy for medulloblastoma: The first multi-centre control trial of the International Society of Pediatric Oncology (SIOP I). Eur J Cancer 1990;26:464–469.
   PubMed Web of Science ®Google Scholar
• Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al Standard-risk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: a French Society of Pediatric Oncology Study. J Clin Oncol 2005;23:4726–4734.
   PubMed Web of Science ®Google Scholar
• Fouladi M, Gururangan S, Moghrabi A, et al Carboplatin-based primary chemotherapy for infants and young children with CNS tumours. Cancer 2009;115:3243–3253.
   PubMed Web of Science ®Google Scholar
• Verlooy J, Mosseri V, Bracard S, et al Treatment of high risk medulloblastomas in children above the age of 3 years: a SFOP study. Eur J Cancer 2006;42:3004–3014.
   PubMed Web of Science ®Google Scholar
• Okada S, Hongo T, Sakaguchi K, Suzuki K, Nishizawa S, Ohzeki T. Pilot study of ifosfamide/carboplatin/etoposide (ICE) for peripheral blood stem cell mobilization in patients with high-risk or relapsed medulloblastoma. Childs Nerv Syst 2007;23:407–413.
   PubMed Web of Science ®Google Scholar
• Dhall G, Grodman H, Ji L, et al Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols. Pediatr Blood Cancer 2008;50:1169–1175.
   PubMed Web of Science ®Google Scholar
• Grodman H, Wolfe L, Kretschmar C. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue. Pediatr Blood Cancer 2009;53:33–36.
   PubMed Web of Science ®Google Scholar
• Packer RJ, Cogen P, Vezina G, Rorke LB. Medulloblastoma: clinical and biologic aspects. Neuro Oncol 1999;1:232–250.
   PubMedGoogle Scholar
• Padovani L, Sunyach MP, Perol D, et al Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults. Int J Radiat Oncol Biol Phys 2007;68:433–440.
   PubMed Web of Science ®Google Scholar
• Brandes AA, Franceschi E, Tosoni A, Blatt V, Ermani M. Long-term results of a prospective study on the treatment of medulloblastoma in adults. Cancer 2007;110:2035–2041.
   PubMed Web of Science ®Google Scholar
• Brandes AA, Ermani M, Amista P, et al The treatment of adults with medulloblastoma: a prospective study. Int J Radiat Oncol Biol Phys 2003;57:755–761.
   PubMed Web of Science ®Google Scholar
• Kunschner LJ, Kuttesch J, Hess K, Yung A. Survival and recurrence factors in adult medulloblastoma: the M.D. Anderson Cancer Center experience from 1978 to 1998. Neuro-oncol 2001;3:167–173.
   PubMed Web of Science ®Google Scholar
• Prados MD, Warnick RE, Wara WM, et al Medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1995;32:1145–1152.
   PubMed Web of Science ®Google Scholar
• Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T Survival and prognostic factors in a series of adults with medulloblastomas. J Neurosurg 2009;111478–487.
   PubMed Web of Science ®Google Scholar
• Tarbell NJ, Loeffler JS, Silver B, et al The change in patterns of relapse in medulloblastoma. Cancer 1991;68:1600–1604.
   PubMed Web of Science ®Google Scholar
• Merchant TE, Wang MH, Haida T, et al Medulloblastoma: Long term results for patients treated with definitive radiation therapy during the computed tomography era. Int J Radiat Oncol Biol Phys 1996;36:29–35.
   PubMed Web of Science ®Google Scholar
• Hughes EN, Shillito J, Sallan SE, et al Medulloblastoma at the Joint Center for Radiation Therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival. Cancer 1988;61:1992–1998.
   PubMed Web of Science ®Google Scholar
• Abacioglu U, Uzel O, Sengoz M, Turkan S, Ober A. Medulloblastoma in adults: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 2002;54:855–860.
   PubMed Web of Science ®Google Scholar
• Oyharcabal-Bourden V, Kalifa C, Gentet JC, et al Standardrisk medulloblastoma treated by adjuvant chemotherapy followed by reduced-dose craniospinal radiation therapy: A French Society of Pediatric Oncology Study. J Clin Oncol 2005;23:4726–4734.
   PubMed Web of Science ®Google Scholar
• Tabori U, Sung L, Hukin J, et al Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma. Int J Radiat Oncol Biol Phys 2006;64:402–407.
   PubMed Web of Science ®Google Scholar
• Le QT, Weil MD, Wara WM, et al Adult medulloblastoma: an analysis of survival and prognosis factors. Cancer J Sci Am 1997;3:238–245.
   PubMed Web of Science ®Google Scholar
• Hartsell WF, Montag AG, Lydon J, Galinsky DL, Sarin P. Treatment of medulloblastoma in adults. Am J Clin Oncol 1992;15:207–211.
   PubMed Web of Science ®Google Scholar
• Skolyszewski J, Glinski B. Results of postoperative irradiation of medulloblastoma in adults. Int J Radiat Oncol Biol Phys 1989;16:479–482.
   PubMed Web of Science ®Google Scholar
• Khafaga Y, Kandil AE, Jamshed A, Hassounah M, DeVol E, Gray AJ. Treatment results for 149 medulloblastoma patients from one institution. Int J Radiat Oncol Biol Phys 1996;35:501–506.
   PubMed Web of Science ®Google Scholar
• Wara WM, Le QT, Sneed PK, et al Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Int J Radiat Oncol Biol Phys 1994;30:551–556.
   PubMed Web of Science ®Google Scholar
• Kochbati L, Bouaouina N, Hentati D, Nasr C, Besbes M, Benna F, Boussen H, Maalej M. Medulloblastoma with extracentral nervous system metastases: clinical presentation and risk factors. Cancer Radiother 2006;10:107–111.
   PubMedGoogle Scholar
• Noël G, Merrer J. Medulloblastoma in adults. Val-de-Grace hospital experience (1975–1994) and literature review. Cancer Radiother 1997;1:60–67.
   PubMedGoogle Scholar
• Taylor RE, Bailey CC, Robinson KJ, et al Impact of radiotherapy parameters on outcome in the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 study of preradiotherapy chemotherapy for M0-M1 medulloblastoma. Int J Radiat Oncol Biol Phys 2004;58:1184–1193.
   PubMed Web of Science ®Google Scholar
• Carrie C, Alapetite C, Mere P, et al Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: The contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group. Radiother Oncol 1992;24:77–81.
   PubMed Web of Science ®Google Scholar
• Peterson K, Walker RW. Medulloblastoma/primitive neuroectodermal tumour in 45 adults. Neurology 1995;45:440–442.
   PubMed Web of Science ®Google Scholar
• Grabenbauer CG, Beck JD, Erhardt J, et al Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome. Am J Clin Oncol 1996;19:73–77.
   PubMed Web of Science ®Google Scholar
• Pizer BL, Clifford SC. The potential impact of tumour biology on improved clinical practice for medulloblastoma: progress towards biologically driven clinical trials. Br J Neurosurg 2009;23:364–375.
   PubMed Web of Science ®Google Scholar